The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Kennedy’s newest decision comes amid a string of vaccine pullbacks at the health department in recent months. In May, he said ...

Research that helped develop mRNA vaccines won the Nobel Prize in Physiology or Medicine in 2023. Members of the scientific community are criticizing Kennedy for his decision.

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

Moderna and BioNTech launched their initial public offerings ("IPOs") within one year of each other, with Modena raising $604m at $23 per share in December 2018, and BioNTech raising $150m at $15 ...

Moderna is not asking that courts take the Pfizer-BioNTech COVID-19 vaccine off the market or to stop future sales, in view of the public need for the vaccines. Moderna and Pfizer's vaccines have ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...